Topping DC, Martin DH, Nettesheim P. Determination of cocarcinogenic activity of benzo[e]pyrene for respiratory tract mucosa.
Cancer Lett 1981;
11:315-21. [PMID:
7296525 DOI:
10.1016/0304-3835(81)90097-5]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
As benzo[e]pyrene (B[e]P) has been shown to enhance the carcinogenic effects of benzo[a]pyrene (B[a]P) on mouse skin [26], it therefore seemed important to determine if it would also act as a cocarcinogen in another target tissue, namely respiratory tract mucosa. Tracheal mucosa of rats was concomitantly exposed to B[a]P and B[e]P for up to 6 months. At B[a]P/B[e]P ratios of 1 : 1 and 0.5 : 1, B[e]P had no cocarcinogenic effects on tracheal epithelium. At the higher B[a]P/B[e]P ratio, B[e]P appeared to reduce the carcinoma incidence from 65% (B[a]P alone) to 40% (B[a]P plus B[e]P). In sharp contrast to the carcinoma incidence, the tracheal and peritracheal sarcoma incidence was enhanced 2-3-fold by B[e]P. Thus, while not cocarcinogenic for tracheal epithelium, B[e]P was cocarcinogenic for connective tissue. Together with other results [26], these point to the importance of the target tissue as a determining factor of cocarcinogenic activity of test substances.
Collapse